Other
Cerebral Perfusion
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
Cerebral Perfusion is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
10
clinical trials
Completed8 · 80%
Withdrawn1 · 10%
Recruiting1 · 10%
Clinical Trials
Trial Activity
10 trials
Physiologic Study of Cerebral Perfusion
Completed·—·Phase 4·NCT02744625·22 enrolled
The Pharmacokinetics of Opioids and Sedative/Hypnotics During Selective Cerebral Perfusion
Completed·—·N/A·NCT00494598·6 enrolled
Neovascularization Induced by Mechanical Barrier disrUption and Systemic Erythropoietin in Patients With Cerebral Perfusion Deficits
Completed·—·Phase 2·NCT02603406·44 enrolled
Cerebral Perfusion Pressure Using Precedex and Other Sedatives
Completed·—·Phase 3·NCT01169467·89 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)